Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Injection Recalled
06/18/2021
Jolynn Tumolo
Fresenius Medical Care Holdings Inc is recalling 48 cases of sodium chloride 0.9% because the product was exposed to temperatures outside specified limits.
Fresenius Medical Care Holdings Inc is recalling 48 cases of sodium chloride 0.9% because the product was exposed to temperatures outside specified limits.
Fresenius Medical Care Holdings...
06/18/2021
Pharmacy Learning Network

Advertisement

News
More Than 300,000 Anesthetic Injections Recalled Over Mix-Up
06/14/2021
Jolynn Tumolo
A label mix-up has prompted Pfizer Inc to recall more than 300,000 vials of the anesthetics lidocaine and bupivacaine.
A label mix-up has prompted Pfizer Inc to recall more than 300,000 vials of the anesthetics lidocaine and bupivacaine.
A label mix-up has prompted...
06/14/2021
Pharmacy Learning Network
News
Subpotent Blood Pressure Drug Recalled
06/14/2021
Jolynn Tumolo
Boehringer Ingelheim Pharmaceuticals Inc is recalling 15,198 bottles of Micardis tablets because the drug is subpotent.
Boehringer Ingelheim Pharmaceuticals Inc is recalling 15,198 bottles of Micardis tablets because the drug is subpotent.
Boehringer Ingelheim...
06/14/2021
Pharmacy Learning Network
News
Anxiety Med Recalled
06/14/2021
Jolynn Tumolo
The FDA has issued a Class II recall for a anxiolytic used to treat anxiety.
The FDA has issued a Class II recall for a anxiolytic used to treat anxiety.
The FDA has issued a Class II...
06/14/2021
Pharmacy Learning Network

Advertisement

News
Course in Drug Literature, Communication Increases Student Pharmacist Confidence
06/12/2021

Jolynn Tumolo

Jolynn Tumolo
“Competent pharmacy practice requires the ability to critically evaluate the medical literature and communicate pharmacotherapy information and recommendations to health care practitioners,” wrote first author Kimberly L Barefield, PharmD, of...
“Competent pharmacy practice requires the ability to critically evaluate the medical literature and communicate pharmacotherapy information and recommendations to health care practitioners,” wrote first author Kimberly L Barefield, PharmD, of...
“Competent pharmacy practice...
06/12/2021
Pharmacy Learning Network
News
ADHD Patches Recalled
06/07/2021
Jolynn Tumolo
A prescription stimulant used to treat attention-deficit/hyperactivity disorder is being recalled.
A prescription stimulant used to treat attention-deficit/hyperactivity disorder is being recalled.
A prescription stimulant used to...
06/07/2021
Pharmacy Learning Network
News
Class I Recall Issued for Subpotent Thyroid Medication
06/07/2021
Jolynn Tumolo
Dozens of lots of subpotent NP Thyroid tablets manufactured for Acella Pharmaceuticals are included in a Class I recall in the June 2, 2021, FDA Enforcement Report.
Dozens of lots of subpotent NP Thyroid tablets manufactured for Acella Pharmaceuticals are included in a Class I recall in the June 2, 2021, FDA Enforcement Report.
Dozens of lots of subpotent NP...
06/07/2021
Pharmacy Learning Network

Advertisement

News
Cough Medicine Recalled
06/01/2021
Jolynn Tumolo
KVK Tech Inc is recalling nearly 18,000 bottles of hydrocodone bitartrate and homatropine methylbromide tablets because the drug failed to meet impurities/degradation specifications.
KVK Tech Inc is recalling nearly 18,000 bottles of hydrocodone bitartrate and homatropine methylbromide tablets because the drug failed to meet impurities/degradation specifications.
KVK Tech Inc is recalling nearly...
06/01/2021
Pharmacy Learning Network
News
Bipolar Drug Recalled
06/01/2021
Jolynn Tumolo
Sigmapharm Laboratories is voluntarily recalling 15,052 bottles of asenapine sublingual tablets because they were manufactured using cherry flavoring instead of black cherry flavoring.
Sigmapharm Laboratories is voluntarily recalling 15,052 bottles of asenapine sublingual tablets because they were manufactured using cherry flavoring instead of black cherry flavoring.
Sigmapharm Laboratories is...
06/01/2021
Pharmacy Learning Network
News
Subpotent Antibiotic Recalled
06/01/2021
Jolynn Tumolo
A Class II recall is active for a prescription antibiotic used to treat a variety of bacterial infections, including uncomplicated urinary tract infections, otitis media, and pharyngitis and tonsillitis.
A Class II recall is active for a prescription antibiotic used to treat a variety of bacterial infections, including uncomplicated urinary tract infections, otitis media, and pharyngitis and tonsillitis.
A Class II recall is active for...
06/01/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use